Quick Answer
Innoviva, Inc. reported Cash and Equivalents of $550.94 million for fiscal year 2025.
Innoviva, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $550.94M | +80.7% |
| 2024 | $304.96M | +57.6% |
| 2023 | $193.51M | -33.5% |
| 2022 | $291.05M | +44.4% |
| 2021 | $201.53M | -18.2% |
| 2020 | $246.49M | -11.4% |
| 2019 | $278.10M | +345.5% |
| 2018 | $62.42M | -14.9% |
| 2017 | $73.34M | -37.9% |
| 2016 | $118.02M | -25.9% |
| 2015 | $159.18M | +64.4% |
| 2014 | $96.80M | -32.5% |
| 2013 | $143.51M | +51.3% |
| 2012 | $94.85M | +111.8% |
| 2011 | $44.78M | -72.6% |
| 2010 | $163.33M | +243.5% |
| 2009 | $47.54M | -48.5% |
| 2008 | $92.28M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $476.51M | +82.8% | +19.9% |
| June 30, 2025 | $397.53M | +83.2% | +24.6% |
| March 31, 2025 | $319.09M | +78.9% | +4.6% |
| December 31, 2024 | $304.96M | +57.6% | +17.0% |
| September 30, 2024 | $260.63M | +44.8% | +20.1% |
| June 30, 2024 | $217.00M | +25.4% | +21.7% |
| March 31, 2024 | $178.36M | +23.8% | -7.8% |
| December 31, 2023 | $193.51M | -33.5% | +7.5% |
- Innoviva, Inc. showed an increase of +80.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, Innoviva, Inc.’s cash and equivalents has grown by 497.0% (from $92.28 million to $550.94 million).
- The most recent figure is from Innoviva, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: